Oncology

Headache Relief Shampoo Voted #1 Best New Product in 2019

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019 / by / in
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Conditions:   Bladder Carcinoma;   Gastric Carcinoma;   Liver and Intrahepatic Bile Duct Carcinoma;   Lung Carcinoma;   Malignant Neoplasm
Intervention:   Procedure: Biospecimen Collection
Sponsors:   University of California, Davis;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 2, 2020 / by / in
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Condition:   Metastatic Non-small Cell Lung Cancer
Interventions:   Drug: Osimertinib;   Drug: Carboplatin;   Drug: Pemetrexed
Sponsors:   Memorial Sloan Kettering Cancer Center;   AstraZeneca;   GUARDANT HEALTH
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 2, 2020 / by / in
Study of the Effect of GM-CSF on Macrophages in Ependymoma
Conditions:   Ependymoma, Recurrent Childhood;   Ependymoma
Intervention:   Drug: Granulocyte Macrophage Colony Stimulation Factor
Sponsors:   University of Colorado, Denver;   National Cancer Institute (NCI);   Children’s Hospital Colorado
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 30, 2020 / by / in
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
Condition:   Prostate Cancer
Intervention:  
Sponsor:   Myriad Genetic Laboratories, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 29, 2020 / by / in
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
Conditions:   Glioblastoma;   GBM;   Glioma
Interventions:   Drug: Abemaciclib;   Drug: LY3214996
Sponsors:   Nader Sanai;   Barrow Neurological Institute;   Ivy Brain Tumor Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 29, 2020 / by / in
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Conditions:   Pancreatic Cancer Stage III;   Pancreatic Cancer Stage IV;   Pancreatic Ductal Adenocarcinoma;   Pancreatic Neoplasms
Intervention:   Procedure: Blood draw
Sponsor:   Western Connecticut Health Network
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 29, 2020 / by / in
NCI COVID-19 in Cancer Patients, NCCAPS Study
Conditions:   Asymptomatic COVID-19 Infection Laboratory-Confirmed;   Hematopoietic and Lymphoid Cell Neoplasm;   Malignant Solid Neoplasm;   Symptomatic COVID-19 Infection Laboratory-Confirmed
Interventions:   Procedure: Biospecimen Collection;   Other: Data Collection
Sponsor:   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 29, 2020 / by / in
Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)
Conditions:   Acute Respiratory Distress Syndrome;   COVID-19
Intervention:   Procedure: Stellate Ganglion Block
Sponsor:   West Virginia University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 28, 2020 / by / in
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
Condition:   Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia
Intervention:   Biological: AUTO1
Sponsor:   Autolus Limited
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 28, 2020 / by / in
Measuring Cell Free Tumor DNA (cfDNA) Levels in Blood and Cerebrospinal Fluid Before, During, and After First-Line Chemotherapy for Primary Central Nervous System Lymphoma
Condition:   Primary Central Nervous System Lymphoma (PCNSL)
Intervention:   Drug: Nivolumab
Sponsors:   Memorial Sloan Kettering Cancer Center;   Bristol-Myers Squibb
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 27, 2020 / by / in